Kallikrein-Kinin Cascade

Encyclopedia of Respiratory Medicine, Four-Volume Set

Volumn , Issue , 2006, Pages 483-493

  Bhoola, K D ^a   Fink, E ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bradykinin; H kininogen; Kallikrein kinins in cancer; Kallikrein kinins in lung diseases; Kinin B 1 receptor; Kinin B 2 receptor; Kinin receptor antagonists; Kininases; L kininogen; Lys bradykinin (kallidin); Plasma kallikrein; Plasma prekallikrein; Tissue kallikrein

Indexed keywords

EID: 78650583245     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-12-370879-6/00204-0     Document Type: Chapter

References (28)

1. Barnes P.J. Bradykinin and asthma. Thorax 1992, 47:979-983.
2. Bhoola K.D., Figueroa C.D., Worthy K. Bioregulation of kinins. kallikreins, kiniogens and kininases. Pharmacological Reviews 1992, 44:1-80.
3. Blaukat A. Structure and signaling pathways of kinin receptors. Andrologia 2003, 35:17-23.
4. Borgono C.A., Diamandis E.P. The emerging roles of human tissue kallikreins in cancer. Nature Reviews: Cancer 2004, 4:876-890.
5. Chan D.C., Gera L., Stewart J.M., et al. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines by a 'biased agonist' mechanism. Proceedings of the National Academy of Sciences, USA 2002, 99:4608-4613.
6. Chan D.C., Gera L., Stewart J.M., et al. Bradykinin antagonist dimer, CU201, inhibits the growth of human cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumour agents. Clinical Cancer Research 2002, 8:1280-1287.
7. Clements J., Hooper J., Dong Y., Harvey T. The expanded human kallikrein ( KLK) gene family: genomic organization, tissue-specific expression and potential functions. Biological Chemistry 2001, 382:5-14.
8. Clements J.A., Willemsen N.M., Myers S.A., Dong Y. The tissue kallikrein family of serine proteases. functional roles in human disease and potential as clinical biomarkers. Critical Reviews in Clinical Laboratory Sciences 2004, 41:265-312.
9. Colman R.W., Schmaier A.H. Contact system. a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood 1997, 90:3819-3843.
10. Cyr M., Eastlund T., Blais C., Rouleau J.L., Adam A. Bradykinin metabolism and hypotensive transfusion reactions. Transfusion 2001, 41:136-150.
11. Davis A.E. The pathophysiology of hereditary angioedema. Clinical Immunology 2005, 114:3-9.
12. Figueroa C.D., Henderson L.M., Kaufmann J., et al. Immunovisualization of high (HK) and low (LK) molecular weight kininogens on isolated human neutrophils. Blood 1992, 79:754-759.
13. Figueroa C.D., MacIver A.G., Bhoola K.D. Identification of a tissue kallikrein in human polymorphonuclear leucocytes. British Journal of Haematology 1989, 72:321-328.
14. Guo Y.-L., Wang S., Colman R.L. Kininostatin an angiogenic inhibitor, inhibits proliferation and induces apoptosis of human endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2001, 21:1427-1433.
15. Haasemann M., Figueroa C.D., Henderson L., et al. Distribution of bradykinin B2 receptors in target cells of kinin action. Visualization of the receptor protein in A431 cells, neutrophils and kidney sections. Brazilian Journal of Medical and Biological Research 1994, 27:1739-1756.
16. Hecquet C., Becker R.P., Tan F.L., Erdös E.G. Kallikreins when activating bradykinin B-2 receptor induce its redistribution on plasma membrane. International Immunopharmacology 2002, 2:1795-1806.
17. Henderson L.M., Figueroa C.D., Muller-Esterl W., Bhoola K.D. Assembly of contact-phase factors on the surface of the human neutrophil membrane. Blood 1994, 84:474-482.
18. Hermann A., Arnhold M., Kresse H., Neth P., Fink E. Expression of plasma prekallikrein mRNA in human nonhepatic tissues and cell lineages suggests special local functions of the enzyme. Biological Chemistry 1999, 380:1097-1102.
19. Mahabeer R., Bhoola K.D. Kallikrein and kinin receptor genes. Pharmacology & Therapeutics 2000, 88:77-89.
20. 1 receptor for kinins. Pharmacological Reviews 1998, 50:357-386.
21. Marceau F., Regoli D. Bradykinin receptor ligands. Nature Reviews 2004, 3:845-847.
22. Neth P., Arnhold M., Nitschko H., Fink E. The mRNAs of prekallikrein, factors XI and XII, and kininogen, components of the contact phase cascade are differentially expressed in multiple non-hepatic human tissues. Thrombosis and Haemostasis 2001, 85:1043-1047.
23. Peek M., Moran P., Mendoza N., Wickramasinghe D., Kirchhofer D. Unusual proteolytic activation of pro-hepatocyte growth factor by plasma kallikrein and coagulation factor XIa. Journal of Biological Chemistry 2002, 277:47804-47809.
24. Plendl J., Snyman C., Naidoo S., Sawant S., Mahabeer R., Bhoola K.D. Expression of tissue kallikrein and kinin receptors in angiogenic microvascular endothelial cells. Biological Chemistry 2000, 381:1103-1115.
25. Poblete M.T., Garces G., Figueroa C.D., Bhoola K.D. Localization of immunoreactive tissue kallikrein in the seromucous glands of the human and guinea-pig respiratory tree. Histochemical Journal 1993, 25:834-839.
26. Renne T., Dedio J., Meijers C.M., Chung D., Müller-Esterl W. Mapping of the discontinuous H-kininogen binding site of plasma prekallikrein - evidence for a critical role of apple domain-2. Journal of Biological Chemistry 1999, 274:25777-25784.
27. Stuardo M., Gonzalez C.B., Nualart F., et al. Stimulated human neutrophils form biologically active kinin peptides from high low molecular weight kininogens. Journal of Leukocyte Biology 2004, 75:631-640.
28. Vidal M.A., Astroza A., Matus C.E., et al. Kinin B2 receptor-coupled signal transduction in human cultured keratinocytes. Journal of Investigative Dermatology 2005, 124:178-186.